BAX and hepatocellular carcinoma: Here, our HCC group demonstrated low Bax levels, whereas Bcl-2, pro-caspase-3, pro-caspase-9, and PARP levels rose, which is consistent with earlier studies by Thomas et al. [61] and Younis et al. [62].